Drug Week articles from May 2004

Drug Week archives from May 2004

Paper further validates brain protein theory.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Prana Biotechnology, Ltd., (PRAN) announced the publication of a new study in which the results further support Prana's theory that metals in the brain, rather than proteins on their own, are...

Novel antibacterial agents for skin infections reviewed.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Researchers review novel antibacterial agents for skin and skin structure infections in a recent issue of the Journal of the American Academy of Dermatology. "With the continuing development of...

3-D agarose matrix used to determine mechanism of cell death by COX-2 inhibitor.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- A 3-dimensional agarose matrix was used to determine the mechanism of cell death by COX-2 inhibitor etodolac. A new method "for studying slow acting pharmaceutical COX-2 inhibitors in the MCF-7...

K579 is long-acting hypoglycemic agent.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- K579, a slow-binding inhibitor of dipeptidyl peptidase IV, is a long-acting hypoglycemic agent. According to recent research from Japan, "Dipeptidyl peptidase IV inhibitors are expected to be...

Board recommends dosing of final two patients in VRX496 trial.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- VIRxSYS Corporation announced that the independent Data Safety Monitoring Board (DSMB) unanimously recommended that the remaining two patients in the company's phase I trial be dosed using VRX496...

BAY 43-9006 receives FDA fast track designation.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Bayer Pharmaceuticals Corporation (BAY) and Onyx Pharmaceuticals, Inc., (ONXX) announced that BAY 43-9006 has been granted Fast Track status by the U.S. Food and Drug Administration (FDA). The...

Report: Aspirin's cardioprotective benefits far outweigh risks.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- A paper published in Cardiovascular Reviews & Reports demonstrates that the benefits of aspirin outweigh the risks when used for prevention of myocardial infarction (MI) in patients determined to be at...

Antibodies that recognize HIV coreceptor-binding site on gp120 studied.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Scientists describe the structural basis of tyrosine sulfation and V[subscript]H-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120 in a recent issue of the...

Attenuated SIV vaccine provides early protection against viral infection.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Vaccination with attenuated simian immunodeficiency virus provided early protection against pathogenic viral infection at a mucosal challenge site. "Atraumatic application of attenuated...

Epitope mimic for human HIV-neutralizing antibody 2G12 synthesized.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Scientists have synthesized a template-assembled oligomannose cluster as an epitope mimic for human HIV-neutralizing antibody 2G12. According to published research from the United States, "The...

HIV synthetic peptide-cocktail prevents SHIV transmission.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- An HIV synthetic peptide-cocktail prevented SHIV transmission in rhesus macaques. "An effective vaccine against human immunodeficiency virus (HIV) should not only protect from infection and...

Low-dose mucosal SIV challenge has same kinetics as high-dose challenge.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge. According to published research from the...

Nasal vaccine controls SHIV viremia and disease progression in primates.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination controlled simian/human immunodeficiency virus viremia and disease progression in nonhuman primates. According to recent research...

Molecular analyses of ALL suggest strategies for more effective treatments.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- The cure rate for pediatric acute lymphoblastic leukemia (ALL) might continue to rise with improved use of conventional therapies. But even more effective and less toxic therapies based on genetic...

Popular citrus soda culprit in patient's medical mystery.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Bill Turner never knew that drinking a popular soda could adversely affect his recovery from a double-lung transplant. What ensued was a true medical mystery, leading to the identification of a new...

Company reports additional FDA clearances for its Gemini system.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has cleared Laserscope's (LSCP) Gemini laser system for three major additional indications, including acne treatment, permanent hair reduction, and wrinkle...

Patch to help cut down alcohol consumption in development.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- A patch that could help drinkers cut down on alcohol is being developed, according to a new report. The patches will contain nicotine, to help smokers get off cigarettes, and a compound called...

Nasal lavage may help allergy sufferers.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Last summer, Bill Schroeder's extreme allergies, inflammation, and infection of his sinuses kept him from tending his beloved garden in rural Wisconsin. This year, Schroeder has already begun to...

Optimal occlusion time for atopy patch test determined for children.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- The optimal occlusion time for the atopy patch test (APT) has been determined for pediatric patients. The APT "is a valuable additional tool in the diagnosis of food allergies in children with...

Mycobacterium vaccae induces regulatory pulmonary CD11c+ cells in mice.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Exposure to a ubiquitous strain of mycobacteria triggers the production of regulatory pulmonary CD11c+ cells in allergic mice. "The hygiene hypothesis proposes that common, harmless microorganisms,...

Eosinophil-produced MIF plays key role in allergic rhinitis.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Eosinophil-produced MIF is involved in the development and subsequent symptoms of allergic rhinitis. Scientists in Japan conducted a study "to assess the potential role of macrophage migration...

Researchers link common airborne bacterium to Alzheimer disease.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Researchers at Philadelphia College of Osteopathic Medicine's Center for the Study of Chronic Diseases of Aging in the Adolph and Rose Levis Alzheimer disease Laboratory have found a possible link...

Current concepts and future prospects for Alzheimer disease vaccines.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Researchers review current concepts and future prospects for Alzheimer disease vaccines in a recent issue of the journal Alzheimer Disease and Associated Disorders. "Alzheimer disease (AD) is the...

Early Alzheimer detection and treatment essential.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Alzheimer disease can't be cured, but discovering it early and treating it with drugs can give the patient a better quality of life, a neurologist from Texas told a Montana conference here. ...

FDA completes review of Propofol IDD-D phase II trial results.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- SkyePharma PLC (SKYE) successfully completed the review of the phase II trial results of Propofol IDD-D with the U.S. Food & Drug Administration. Propofol IDD-D is licensed in North America to Endo...

Case made for using awareness monitoring in surgical patients.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Patients describe it as like being buried alive. The worse part is not the pain, they say, although that can be excruciating, but the horror of being paralyzed, unable to talk and yet totally aware of...

FDA approves CardizemLA.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Biovail Corp. (BVF) announced that the U.S. Food and Drug Administration has approved CardizemLA for the treatment of chronic stable angina. CardizemLA can be given orally once daily, either in the...

Antioxidants may mediate exercise-induced drop in platelet activity.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Antioxidants may mediate exercise-induced reductions in platelet activity. Researchers in Italy conducted a study "to evaluate in sedentary individuals the effects of a 20-week exercise training...

LPS-induced COX-2 expression attenuated in diabetic blood vessels.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- COX-2 expression and prostacyclin production after lipopolysaccharide (LPS) stimulation are attenuated in diabetic blood vessels. According to recent research published in the journal Naunyn -...

Suprax launched in the U.S.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Lupin, Ltd., has now launched its anti-infective product Suprax (cefixime Oral Suspension) in the U.S. The newly established, 50-strong, pediatric-specialty sales force of the company's subsidiary,...

AACR data indicate strong synergy of Hsp90 inhibitor, 17-AAG.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Kosan Biosciences (KOSN) announced, at the American Association for Cancer Research, preclinical in vitro data on the cytotoxic and antiproliferative effects of Kosan's lead Hsp90 inhibitor, 17-AAG,...

Oncology company licenses cancer compound to NeoRx.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- AnorMED, Inc., (AOM) announced that it has licensed its platinum-based anticancer agent, AMD473, to NeoRx Corporation (NERX). Under the terms of the agreement, NeoRx was granted exclusive global...

CLEAR II registry launched.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Enzon Pharmaceuticals, Inc., (ENZN) announced a major new initiative to build upon the value of its CLEAR (Collaborative Exchange of Antifungal Research) patient registry with the launch of CLEAR II....

Plasmodium falciparum drug resistance in India determined.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- The prevalence and patterns of Plasmodium falciparum drug resistance in India have been characterized. In a recent study, the P. falciparum "chloroquine resistance transporter (Pfcrt) K76T mutation...

EGCG inhibits radiation-induced apoptosis by inactivating capase pathway.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Polyphenol EGCG inhibits radiation-induced apoptosis by inactivating the capase pathway in HaCaT cells. "Green tea is a rich source of polyphenols, and (-)-epigallocatechin-3-gallate (EGCG) is a...

Heat shock protein promotes presentation of antigens to immune system.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Recombinant human heat shock protein 60 (HuHsp60) facilitates the presentation of antigenic proteins to the immune system. According to a study from England, "Cross-reactive T cell recognition of...

NO scavenging underlies hypertensive effects on Hb-based blood substitutes.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Nitric oxide [NO] scavenging underlies the hypertensive effects of hemoglobin [Hb]-based blood substitutes. "The major pathway for nitric oxide scavenging in red cells involves the direct reaction...

Intracytoplasmic sperm injection works when oocytes have abnormal structures.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Intracytoplasmic sperm injection works when oocytes have abnormal structures. According to recent research from Israel, "a couple with unexplained infertility was referred for routine in vitro...

Multiple birth rates after assisted reproductive techniques have leveled off.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Multiple birth rates after assisted reproductive techniques have leveled off. "European results of assisted reproductive techniques from treatments initiated during 2000 are presented in this fourth...

Parents' feelings and official practices governing stored embryos vary.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Parents' feelings and official practices governing stored embryos vary. According to a study from the United States, "cryopreservation of embryos is frequently employed in in vitro fertilization...

Three key variables predict the success of intrauterine insemination.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Three key variables predict the success of intrauterine insemination. "This study was performed to predict pregnancy by intrauterine insemination (IUI) using computer-aided sperm analysis (CASA)...

Role of costimulatory molecules in allergy and asthma reviewed.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Scientists review the role of costimulatory molecules in allergy and asthma in a recent issue of Springer Seminars in Immunopathology. "Activation and differentiation of T cells play a critical...

Xolair forecasted to lead the growth of the asthma drug market in 2012.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., forecasts that Genentech/Novartis/Sankyo/Tanox Biosystems' Xolair will lead the growth of the asthma market with major-market sales of $3.3 billion in 2012. According to...

Poor glycemic control increases asymptomatic bacteriuria risk in women.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Poor metabolic control increases the risk of asymptomatic bacteriuria in women with diabetes. According to recent research from Italy, "We screened 228 women with diabetes for bacteriuria during...

Novel platelet proteins located in human atherosclerotic lesions.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Characterization of the proteins released from activated platelets led to localization of novel platelet proteins in human atherosclerotic lesions. "Proteins secreted by activated platelets can...

Microbes that produce hydrogen peroxide reduce obstetrical complications.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Microbes that produce hydrogen peroxide reduce obstetrical complications. According to recent research published in the Journal of Clinical Microbiology, "lactobacilli, principally the strains that...

E. coli LPS induces heat shock protein 25 in intestinal cells.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Escherichia coli lipopolysaccharides induce heat shock protein 25 in intestinal epithelial cells through mitogen-activated protein (MAP) kinase activation. According to a study from the United...

Pasteurella multocida contains multiple hemoglobin-binding proteins.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Pasteurella multocida contains multiple immunogenic hemin- and hemoglobin-binding proteins. According to a study from Spain, "Iron-dependent outer membrane proteins (IROMPs) play an important role...

Study demonstrates improvements in BPH symptoms with AVODART.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- New clinical study findings showed that men with symptoms of benign prostatic hyperplasia (BPH), also known as enlarged prostate, taking AVODART for 4 years had sustained, long-term improvement in three...

Engineered fibrin matrices boost the study of angiogenesis-linked therapy.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Engineered fibrin matrices boost the study of angiogenesis-linked therapy. According to published research from Switzerland, "with the rapid increase in approaches to pro- or anti-angiogenic...

New models depict endothelial patterning during tubulogenesis.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- New models depict endothelial patterning during tubulogenesis. "In vitro angiogenesis assays have shown that tubulogenesis of endothelial cells within biogels, like collagen or fibrin gels, only...

New techniques embed pDNA in collagen scaffolds more effectively.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- New techniques embed pDNA in collagen scaffolds more effectively. According to a study from Israel, "collagen matrices can be used as non-viral biocompatible gene carriers for localized implantable...

Reengineered salivary glands act as bioreactors for systemic gene therapies.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Reengineered salivary glands act as bioreactors for systemic gene therapies. According to published research from the United States, "the use of critical-for-life organs (e.g., liver or lung) for...

Decision support system developed for measurement of operational efficiency.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- A novel system has been developed for measuring the operational efficiency of blood banks. J.F. Kros and colleagues at East Carolina University described a "decision support system (DSS)" that...

Bordetella holmesii bacteremia is a problem in asplenic patients.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Bordetella holmesii bacteremia is a newly recognized clinical entity among asplenic patients. "Bordetella holmesii is a recently identified Gram-negative bacterial species associated with...

Proton magnetic resonance spectroscopy can monitor glioma response to treatment.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Monitoring low-grade glioma response to temozolomide can be accomplished using proton magnetic resonance spectroscopy (H-1-MRS), researchers say. "Assessment of low-grade glioma treatment response...

Aromatase inhibitors may replace tamoxifen.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- A 4-year update of the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial showed that patients on anastrozole have longer disease-free survival, lower incidence of contralateral breast cancer, and...

CXCR4 expressed in DCIS of the breast and atypical ductal hyperplasia.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- CXCR4 is expressed in DCIS of the breast and atypical ductal hyperplasia, and may play a key role in the development of these malignancies. "Recent evidence attributed important influence to...

Drug development company doses first patient in breast cancer study.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- YM BioSciences Inc. (YM) announced that the first patient has been dosed in its 700-patient phase III registration trial for metastatic breast cancer. The international pivotal trial is designed to...

Perillyl alcohol inhibits human breast cancer cell growth in mice.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Researchers report that monoterpene perillyl alcohol (POH) administered to nude mice inhibited breast cancer cell growth. According to a study from Japan, "The effect of POH on cell growth, cell...

Progenta breast cancer treatment data presented at cancer research meeting.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Zonagen, Inc., (ZONA) announced that data generated at Zonagen in collaboration with scientists at the University of Illinois-Chicago that indicate the potential for Progenta for the treatment of breast...

Studies: INGN 241 enhances antitumor effects of Herceptin.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Preclinical data presented at the 95th annual meeting of the American Association of Cancer Research demonstrate that INGN 241 enhances the antitumor effects of Herceptin (Trastuzumab) in HER2-positive...

Implications of estrogen receptor beta in breast cancer outlined.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- The implications of the estrogen receptor beta for patients with breast cancer are outlined in a recent issue of Lancet Oncology. "Estrogen receptor (ER) a is a well established prognostic marker...

"Crystal engineering" helps scientists solve 3-D protein structures.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- A new technique for engineering protein crystals is helping scientists figure out the three-dimensional structures of some important biological molecules, including a key plague protein whose structure...

BioBalance parent's 2003 revenues come solely from healthcare services.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- New York Health Care, Inc., (BBAL) announced financial results for the year ended December 31, 2003. Net patient service revenues of $45,060,449 were entirely generated from its healthcare services...

Biopharmaceutical company announces plans for CDT platform.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- SCOLR, Inc., (DDD) announced its intention to use its controlled delivery technology (CDT) platform to independently develop a select portfolio of controlled release solid oral medications for...

Business strategy and financial results announced by pharmaceutical company.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Zonagen, Inc., (ZONA) announced that the company's newly elected board of directors together with management have determined that the near-term business strategy for Zonagen is to concentrate its...

Calcitonin licensing and manufacturing agreements announced.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Unigene Laboratories, Inc., (UGNE) has signed licensing and clinical supply agreements with Novartis Pharma AG (NVS) to provide for the recombinant production of calcitonin, the active ingredient used...

Conclusion of joint venture relationship announced.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corporation (TGEN) announced an agreement with Elan Corporation, plc, (ELN) that formally concludes the collaboration between the companies through the joint venture, Emerald Gene...

Neurological company consolidates operations as it reaches new level of growth.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Neurochem, Inc., (NRMX) has signed a conditional agreement to purchase the Shire BioChem facilities located in the Parc Scientifique et de Haute Technologie de Laval (Quebec) for CDN$10.5 million. ...

Pharmaceutical company to close manufacturing facility.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Organon USA Inc., part of the human pharmaceutical business unit of Akzo Nobel, announced its intent to close its West Orange, New Jersey, injectable drug manufacturing facility, effective on or about...

PhotoPoint company reports progress during 2003, including lower net loss.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Miravant Medical Technologies (MRVT), a pharmaceutical development company specializing in PhotoPoint photodynamic therapy (PDT), announced consolidated financial results for the fourth quarter and the...

Strategic alliance announced by biopharmaceutical company.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Xechem International Inc. (XKEM) has entered into a memorandum of understanding with Alembic, Limited, and believes the strategic alliance established by this agreement will enhance and accelerate its...

U.S. OTC sales reach $17.5B in 2003, analysis shows.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Preliminary results from the 2003 edition of Kline & Company's Nonprescription Drugs U.S.A annual market analysis indicate that the U.S. market for over-the-counter (OTC) medications grew 5.2% from 2002...

Layoffs confirmed by OxyContin maker.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- OxyContin maker Purdue Pharma confirmed April 13, 2004, that it is laying off about 300 people, or about 9% of its work force, as its mainstay painkiller faces generic competition for the first time....

MIT's Deshpande strikes first funding and licensing deals.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- In the first transactions fulfilling its promise to bridge the gap between university research and commercialization, The Deshpande Center for Technological Innovation at the Massachusetts Institute of...

Medicine-flavoring company partners with 10 new providers.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- FLAVORx, a formulary system used by pharmacists to safely add flavorings to liquid medications to improve taste and increase compliance, announced the partnerships with nine new pharmacy chains and a...

NeoRx sells Pretarget intellectual property, announces resignation of VP.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- NeoRx Corp. (NERX), a cancer therapeutics development company, announced that it has executed an agreement with privately held Aletheon Pharmaceuticals, Inc., for the sale and transfer of NeoRx's...

PBM's discount drug card approved by Medicare.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- MedImpact Healthcare Systems, Inc. (MedImpact), a pharmacy benefit manager, announced that the Center for Medicare & Medicaid Services (CMS) has approved the company's drug discount card (DDC) program....

Pharmaceutical company presents data at cancer research meeting.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Peregrine Pharmaceuticals, Inc., (PPHM) presented new data at the American Association of Cancer Research annual meeting. The presented research included data related to its tumor necrosis therapy...

U.S. FDA issues agreement for Interleukin 21 phase I cancer study.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- ZymoGenetics (ZGEN) has received agreement from the U.S. Food and Drug Administration (FDA) to begin a phase I clinical study with Interleukin 21 (IL-21), a recombinant human protein being developed by...

Validated cancer SNP assays launched using MGB Eclipse Probe Systems.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Epoch Biosciences, Inc., (EBIO), a provider of proprietary products that accelerate genomic analysis, announced that a new panel of assays targeting single nucleotide polymorphisms (SNPs) identified by...

Interferon-alpha stops the formation of liver cancer in animal models.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Interferon-alpha stops the formation of liver cancer in animal models. According to a study from Japan, "interferon (IFN)-alpha treatment is a common therapy for chronic viral hepatitis and...

Proteomic approaches in cancer risk and response assessment described.
May 7, 2004... 2004 MAY 7 - (NewsRx.com & NewsRx.net) -- Researchers describe proteomic approaches in cancer risk and response assessment in a recent issue of Trends in Molecular Medicine. "Proteomics is more than just a list-generating exercise where...